|
Intervention group
|
0.2 (−0.6;−0.9)
|
0.69
| | |
|
Female gender
|
−3.0 (−3.8;−2.3)
|
<0.001
| | |
|
Age <35 years
|
−0.3 (−1.1;−0.6)
|
0.54
| | |
|
Severe HIV (clinical stage 3 or 4)
|
−2.1 (−2.8;−1.4)
|
<0.001
| | |
|
History of IDU
|
−2.1 (−2.8;−1.4)
|
<0.001
| | |
|
ART-non-naïve status
|
0.8 (−0.8;2.5)
|
0.32
| | |
|
TB history
|
−0.2 (−1.2;0.8)
|
0.68
| | |
|
VL at baseline ≥100,000 copies/ml
|
−2.8 (−3.6;−2.0)
|
<0.001
|
−0.9 (−1.5;−0.3)
|
<0.01
|
|
CD4 at baseline <100 cells/μl
|
−6.8 (−7.4;−6.3)
|
<0.001
|
−5.7 (−6.3;−5.1)
|
<0.001
|
|
Having an HIV-infected family member
|
2.5 (1.8;3.3)
|
<0.001
|
1.3 (0.8;1.9)
|
<0.001
|
|
From Ha long CDC OPC
|
−0.5 (−1.2;0.3)
|
0.22
| | |
|
History of OIs
|
1.1 (0.3;1.9)
|
<0.01
| | |
|
Changed ART regimen
|
1.0 (0.1;1.8)
|
<0.05
| | |
|
Incomplete adherence (missing more than one doses in 24 months)
|
−1.3 (−3.1;0.5)
|
0.15
| | |
|
Month
|
0.4 (0.4;0.4)
|
<0.001
|
0.39 (0.38;0.41)
|
<0.001
|
